AIFF vs JAZZ · rev $999.0K vs P/E 1988, rev $2.28B
Firefly Neuroscience, Inc. (AIFF) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Firefly Neuroscience, Inc. (AIFF) is a software - application company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported AIFF revenue for 2026-06-30 was $999.0K. Net income was -$4.0M. AIFF currently screens at market cap $38.8M.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
AIFF currently screens at market cap $38.8M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the AIFF and JAZZ stock pages for the full models.
Not investment advice.